-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, V720mSx/8DBIXxcMxpWnLwE8UHd6w8WNdXY2m6wZBL8QH8iYLT4ZtKtp9kxNzy3B tZ7BsyJuJZdemPRQQwhWJw== 0000910484-96-000049.txt : 19960604 0000910484-96-000049.hdr.sgml : 19960604 ACCESSION NUMBER: 0000910484-96-000049 CONFORMED SUBMISSION TYPE: 10-C PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 19960530 FILED AS OF DATE: 19960603 SROS: NASD FILER: COMPANY DATA: COMPANY CONFORMED NAME: ARONEX PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000854691 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 760196535 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-C SEC ACT: 1934 Act SEC FILE NUMBER: 000-20111 FILM NUMBER: 96576061 BUSINESS ADDRESS: STREET 1: 3400 RESEARCH FOREST DR CITY: THE WOODLANDS STATE: TX ZIP: 77381 BUSINESS PHONE: 7133671666 MAIL ADDRESS: STREET 1: 3400 RESEARCH FOREST DRIVE CITY: THE WOODLANDS STATE: TX ZIP: 77381 10-C 1 ARONEX PHARMACEUTICALS, INC. FORM 10-C FORM 10-C SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 Report by issuer of securities quoted on The Nasdaq Stock Market(sm), filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 and Rule 13a-17 or 15d-17 thereunder. EXACT NAME OF ISSUER AS SPECIFIED IN CHARTER: Aronex Pharmaceuticals, Inc. ---------------------------- ADDRESS OF PRINCIPAL EXECUTIVE OFFICES: 3400 Research Forest Drive, The ----------------------------------- Woodlands, Texas 77381 - ---------------------- ISSUER'S TELEPHONE NUMBER (INCLUDING AREA CODE): (713) 367-1666 I. Change in Number of Shares Outstanding Indicate any change (increase or decrease) of five percent or more in the number of shares outstanding: 1. Title of security Common Stock ------------ 2. Number of shares outstanding before the change 22,020,283 ---------- 3. Number of shares outstanding after the change 28,920,283 (as of May 30, -------------------------- 1996) ----- 4. Effective date of change May 22, 1996 (initial closing) and May 30, 1996 ------------------------------------------------- (over-allotment) ---------------- 5. Method of change New issuance ------------ Specify method (such as merger, acquisition, exchange, distribution, stock split, reverse split, acquisition of stock for treasury, etc.) Give brief description of transaction Public offering of 6,900,000 shares of Common Stock --------------------------------------------------- II. CHANGE IN NAME OF ISSUER 1. Name prior to change 2. Name after change 3. Effective date of charter amendment changing name 4. Date of shareholder approval of change, if required May 31, 1996 /s/ Terance A. Murnane Controller and Secretary - ------------------------------------------------------------------------------- DATE OFFICER'S SIGNATURE AND TITLE -----END PRIVACY-ENHANCED MESSAGE-----